Xcout Intel
Endurance Biotech, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Endurance Biotech, Inc. among biotechnology companies — ranked by similarity to what Endurance Biotech, Inc. actually does, not by market-cap band.
Subscribe to see Endurance Biotech, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Endurance Biotech, Inc.
Endurance Biotech, Inc. is a biopharmaceutical company that develops first-in-class oral small molecules designed to restore mitochondrial and lysosomal function for the treatment of neurodegenerative, metabolic, and age-related diseases. Its lead clinical program, T-168, targets Parkinson's disease by addressing interconnected cellular systems, reducing neuroinflammation, and enhancing autophagy.
Endurance Biotech, Inc. at a glance
Endurance Biotech, Inc. is a biotechnology company headquartered in United States. It has raised at least $20.5M across the 2 funding rounds on record. Its most recent funding round, Series B, raised $11.7M in January 2018. Xcout tracks 7 named people at Endurance Biotech, Inc., including Subhasis Roy (CFO - CBO).
Endurance Biotech, Inc. leadership
- Subhasis RoyCFO - CBO
- Frederic GodderisFounder · CEO · Director
- Sanjay KakkarFounder · Director · CEO, Tensive SRL · Former Chairman, Tranquis Therapeutics
- Andrew LamCo-founder · Chief Technology Officer
- Enchi LiuCo-founder · Chief Development Officer
- Jackson StreeterFlorida Opportunity Fund / Director, UF Innovate Ventures / Partner, DeepWork Capital
1 more named person on record for Endurance Biotech, Inc., with roles, board committees and tenure — see the full roster →
Endurance Biotech, Inc. funding rounds
At least $20.5M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $11.7M | 1 named | |
| SEC Form D filing | $8.8M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Endurance Biotech, Inc. competitors
Ranked by semantic similarity — how close each company is to Endurance Biotech, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Autonomy Bio Inc. is a biotechnology company focused on developing human aging therapeutics aimed at extending healthspan and mitigating age-related decline. The company targets individuals seeking to maintain health and independence as they age.
Similar biotechnology company
Endeavor BioMedicines, Inc. is a San Diego-based biotechnology company focused on developing novel treatments for conditions such as fibrosis.
Similar biotechnology company
Vandria is a biotechnology research company founded in September 2021 and based at the Biopôle campus in Epalinges, Switzerland. The company specializes in discovering first-in-class small molecules targeting mitochondrial function to treat age-related diseases. It operates with a small team focused on novel metabolic pathways.
Similar biotechnology company
CuraSen Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops novel therapies to treat neurodegenerative diseases by targeting specific receptor systems in the brain. The company's scientific approach focuses on restoring neurovascular and neuronal function to serve patients suffering from conditions such as Parkinson's disease and other neurodegenerative disorders.
Similar biotechnology company
Arkuda Therapeutics is a biotechnology company developing small-molecule treatments for neurodegenerative diseases, with a focus on restoring lysosomal function and addressing progranulin-related disease biology. Its programs are aimed particularly at patients with frontotemporal dementia and other disorders involving lysosomal dysfunction.
Biotech
Synendos Therapeutics is a clinical-stage biopharmaceutical and neuroscience company focused on developing a novel class of small molecules to treat psychiatric and neurological disorders.
Biotech
ScandiBio Therapeutics is a clinical-stage biotechnology company headquartered in Stockholm, Sweden, founded to develop pharmaceutical drugs targeting mitochondrial dysfunction.
Similar biotechnology company
FoldLogic Bio is a clinical-stage biotechnology company developing targeted immunotherapies for neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Multiple System Atrophy. The company focuses on modulating the central nervous system's immune responses, specifically targeting microglial activity, alpha-synuclein, and TREM2 to halt disease progression.
Biotech
Polaryx Therapeutics, Inc. functions as a biotechnology firm dedicated to advancing small-molecule therapies for lysosomal storage and neurodegenerative conditions. Its developmental pipeline includes a trio of promising candidates: PLX-100, which combines PLX-200 with an ancillary supplement, targeting late infantile neuronal ceroid lipofuscinosis (LINCL) and related forms of NCL. PLX-200, a repurposed compound already utilized to address various diseases in both adult and pediatric populations. And PLX-300, derived from an edible plant, which works by activating PPARa to enhance the production of transcription factor EB. The company, established in 2014, maintains its base of operations in Paramus, New Jersey.
Life Sciences
Libra Therapeutics is a biopharmaceutical company headquartered in Del Mar, California, focused on developing novel disease-modifying therapeutics. The company aims to restore cellular balance and improve lysosomal function to halt neurodegeneration in conditions such as amyotrophic lateral sclerosis.
Similar biotechnology company
Cambrian BioPharma, Inc. is a biotechnology company headquartered in New York, United States, focused on developing therapeutics to extend human healthspan.
Similar biotechnology company
Ora Biomedical, Inc. is a longevity biotechnology pharmaceutical company headquartered in Tukwila, Washington, that identifies and develops longevity therapeutics and small molecules.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Endurance Biotech, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Endurance Biotech, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →